Simulations Plus Company Description
Molecular modeling software plus applications to help individuals with disabilities equals Simulations Plus. The company is a leading provider of applications used by pharmaceutical researchers to model absorption rates for orally dosed drug compounds. Its Words+ subsidiary provides augmentative communication software and input devices that help people with disabilities use computers. Simulations Plus also provides educational software targeted to high school and college students through its FutureLab unit. Pharmaceutical giants GlaxoSmithKline and Roche are among its clients. CEO Walter Woltosz and his wife, Virginia (a director), together own about half of the company.
View the Comprehensive Company Description for Simulations Plus
The Company Description provides a historical perspective of Simulations Plus's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Simulations Plus's evolution in the marketplace.
